HEPATITIS
NEWS The top stories compiled
from over 5,500 sources, updated every 15 minutes
Research from University of Paris in hepatitis a vaccines provides new insights
- (NewsRx.com) -- A new study, 'Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study,' is now available (see also ). According to recent research from Paris, France, 'The immunogenicity of vaccines,
WRHA says 17 people exposed to HIV, hepatitis risk
The Winnipeg Regional Health Authority is trying to contact 17 people who may have been exposed to infections because of a nurse's improper use of a blood-sampling device at a St. Boniface clinic. The exposure risk of infections possibly including
Who Will Respond to Hepatitis C Treatment
The relatively new field of proteomics may be able to predict who will respond to Hepatitis C therapy - before treatment even begins....
HCV May Be Able to Be Cleared from Both Blood and Liver
Viral clearance doubled in a Hepatitis C Phase II trial during standard therapy when coupled with GlobeImmune's GI-5005. Because Hepatitis C must be eradicated not just from the blood, but also the liver, GI-5005's ability to speed the clearance rate...
Information at this website is for educational purposes
only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.